Fungal infections in women, especially vaginal fungal infections (also known as vaginal candidiasis or vaginal yeast infection), are among the most common health problems. These infections are usually caused by a type of fungus called Candida albicans. Although this fungus is naturally present in the body, under certain conditions it can overgrow and cause infection.

Clinical symptoms of fungal infections

The most important infections that cause infertility:

Mycoplasma fungal infections are colonized in the genital tracts of healthy and sexually active men and women and are transmitted through sexual contact.

Symptoms:

From asymptomatic to dyspronia and excessive vaginal discharge

Complications:

With the increase, the risk of endometritis, PID and infertility, miscarriage, premature rupture of the membranes and premature birth are associated.

Adverse fetal consequences include:

Meningitis, pneumonia, brain abscesses in babies

Diagnosis:

PCR test

Gonococcal fungal infections can cause preterm labor, pRom, low birth weight, and perinatal mortality. Untreated gonococcal cervicitis is associated with septic abortion.

Risk factors:

  • Pregnant women who live in densely populated areas.
  • Age less than 25 years
  • Those who have had or currently have sexually transmitted diseases
    sex workers
  • Multiple sexual partners
  • New sexual partner
  • In gonorrhea infection, mucous secretions are purulent.

Clinical symptoms:

Mucous, purulent cervicitis and infection of the vestibular glands, in cases where bacteria enter the blood, skin symptoms such as petechiae and systemic symptoms such as arthralgia are added.

chlamydia

The role of these fungal infections in pregnancy is controversial. Some believe that untreated infection increases the rate of preterm birth, PPROM, low birth weight or perinatal mortality. Chorioamnionitis is debated. However, delayed uterine infection occurs after delivery. General transmission of infection causes conjunctival infection and infant pneumonia.

The American College of Gynecologists 2017 recommends chlamydia screening for all women at their first prenatal visit. In addition, it recommends testing in the third trimester for those treated in the first trimester.

Diagnosis:

Primarily performed by NAAT, samples from cervical vaginalia are preferred.

  • Group B streptococcal infections
  • There are a group of bacteria that are mostly placed in the vagina and anus. They usually have no symptoms
    In pregnant women, group B streptococcus causes bacteriuria and chorioamnionitis, and vertical transmission to infants can cause pneumonia, meningitis, endocarditis, bacteremia.
  • Antibiotic injection can significantly reduce the risk of transmission of group B streptococcal infection to the fetus.
  • GBS test is performed between 35 and 37 weeks of pregnancy
  • Diagnosis through vaginal and rectal cultures

If this infection is diagnosed, treatment begins.

Syphilis

  • The first stage is painless, circular sores (chancre) in the mouth, anus or genitals (3 to 6 weeks).
  • The secondary stage of syphilis is itchy skin lesions, latent syphilis occurs when primary and secondary syphilis are not treated
  • Latent stage of syphilis without symptoms with visible symptoms
  • The third stage (tertiary) affects different organs of the body such as eyes, nerves, heart, liver, blood vessels, bones and joints

Syphilis screening is recommended in all pregnant women to prevent congenital infections

Syphilis fungal infections can lead to premature birth, low birth weight and death of the fetus or infant.

The test is performed at the first pregnancy visit. In populations with a high prevalence of syphilis or in people with risk factors, the serology test is repeated after the 28th week of pregnancy and again during delivery.

Two types of serological tests are used for diagnosis and screening.

  • The first type of non-treponemal VDRL or RPR test (both tests are based on IgM and IgG)
  • The second type to confirm the presence of specific antibodies

FTA-ABS body treponemalantibody tests and agglutination of inactive apallidum particles Tp-pA